ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global FPR1 Activator Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-13C17176
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global FPR1 Activator Market Research Report 2024
BUY CHAPTERS

Global FPR1 Activator Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13C17176
Report
November 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sigma-aldrich
Cayman Chemical
Tocris Bioscience
Abcam
R&D Systems
MedChemexpress LLC
Santa Cruz Biotechnology
BioVision
Enzo Life Sciences
Selleck Chemicals
AppTec
Zhiyuan Biotechnology
Liding Biotechnology
R&D Systems

FPR1 Activator Market Size

The global FPR1 Activator market is projected to grow from US$ 71.7 million in 2024 to US$ 133 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

FPR1 Activator Market

FPR1 Activator Market

FPR1 activators refer to compounds or substances that can activate FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that is widely present in various types of leukocytes. It can recognize and bind bacterial-derived N-formyl peptides and is involved in regulating biological processes such as inflammation, immunity, and cell migration. FPR1 activators promote the generation of relevant biological responses by binding to FPR1 and initiating its signal transduction pathway, and are used to study the role of FPR1 in physiological and pathological processes and the development of treatment strategies for related diseases.
The FPR1 activator market is currently in a phase of steady growth. With in-depth research on the role of FPR1 (Formyl Peptide Receptor 1) in physiological processes such as inflammatory response, cell migration, and cancer development, the value of FPR1 activators in scientific research and clinical applications has gradually been discovered. Particularly in the fields of oncology and immunology, FPR1 activators are viewed as a potential therapeutic strategy capable of modulating cellular and immune responses to combat disease. With a deeper understanding of the role of FPR1 in disease, the potential of FPR1 activators in disease diagnosis and treatment is gradually emerging. In the future, as more clinical trials are conducted and verified, FPR1 activators will have broader prospects in clinical application. In summary, the FPR1 activator market has broad development prospects and huge market potential.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global FPR1 Activator market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of FPR1 Activator Market Report

Report Metric Details
Report Name FPR1 Activator Market
Accounted market size in 2024 US$ 71.7 million
Forecasted market size in 2031 US$ 133 million
CAGR 9.4%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Natural Product Activator
  • Synthetic Activator
Segment by Application
  • Biomedicine
  • Drug Discovery
  • Clinical Diagnosis
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sigma-Aldrich, Cayman Chemical, Tocris Bioscience, Abcam, R&D Systems, MedChemExpress, Santa Cruz Biotechnology, BioVision Inc., Enzo Life Sciences, Selleck Chemicals, APPTEC, Liding Biotechnology, Zhiyuan Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the FPR1 Activator study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is FPR1 Activator Market growing?

Ans: The FPR1 Activator Market witnessing a CAGR of 9.4% during the forecast period 2025-2031.

What is the FPR1 Activator Market size in 2031?

Ans: The FPR1 Activator Market size in 2031 will be US$ 133 million.

Who are the main players in the FPR1 Activator Market report?

Ans: The main players in the FPR1 Activator Market are Sigma-Aldrich, Cayman Chemical, Tocris Bioscience, Abcam, R&D Systems, MedChemExpress, Santa Cruz Biotechnology, BioVision Inc., Enzo Life Sciences, Selleck Chemicals, APPTEC, Liding Biotechnology, Zhiyuan Biotechnology

What are the Application segmentation covered in the FPR1 Activator Market report?

Ans: The Applications covered in the FPR1 Activator Market report are Biomedicine, Drug Discovery, Clinical Diagnosis

What are the Type segmentation covered in the FPR1 Activator Market report?

Ans: The Types covered in the FPR1 Activator Market report are Natural Product Activator, Synthetic Activator

1 Study Coverage
1.1 Introduction to FPR1 Activator: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global FPR1 Activator Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Natural Product Activator
1.2.3 Synthetic Activator
1.3 Market Segmentation by Application
1.3.1 Global FPR1 Activator Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomedicine
1.3.3 Drug Discovery
1.3.4 Clinical Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global FPR1 Activator Revenue Estimates and Forecasts 2020-2031
2.2 Global FPR1 Activator Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global FPR1 Activator Sales Estimates and Forecasts 2020-2031
2.4 Global FPR1 Activator Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global FPR1 Activator Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global FPR1 Activator Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Natural Product Activator Market Size by Manufacturers
3.5.2 Synthetic Activator Market Size by Manufacturers
3.6 Global FPR1 Activator Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global FPR1 Activator Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global FPR1 Activator Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global FPR1 Activator Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global FPR1 Activator Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America FPR1 Activator Sales and Revenue by Type (2020-2031)
6.4 North America FPR1 Activator Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America FPR1 Activator Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe FPR1 Activator Sales and Revenue by Type (2020-2031)
7.4 Europe FPR1 Activator Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe FPR1 Activator Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific FPR1 Activator Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific FPR1 Activator Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific FPR1 Activator Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America FPR1 Activator Sales and Revenue by Type (2020-2031)
9.4 Central and South America FPR1 Activator Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America FPR1 Activator Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa FPR1 Activator Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa FPR1 Activator Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa FPR1 Activator Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sigma-Aldrich
11.1.1 Sigma-Aldrich Corporation Information
11.1.2 Sigma-Aldrich Business Overview
11.1.3 Sigma-Aldrich FPR1 Activator Product Models, Descriptions and Specifications
11.1.4 Sigma-Aldrich FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Sigma-Aldrich FPR1 Activator Sales by Product in 2024
11.1.6 Sigma-Aldrich FPR1 Activator Sales by Application in 2024
11.1.7 Sigma-Aldrich FPR1 Activator Sales by Geographic Area in 2024
11.1.8 Sigma-Aldrich FPR1 Activator SWOT Analysis
11.1.9 Sigma-Aldrich Recent Developments
11.2 Cayman Chemical
11.2.1 Cayman Chemical Corporation Information
11.2.2 Cayman Chemical Business Overview
11.2.3 Cayman Chemical FPR1 Activator Product Models, Descriptions and Specifications
11.2.4 Cayman Chemical FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cayman Chemical FPR1 Activator Sales by Product in 2024
11.2.6 Cayman Chemical FPR1 Activator Sales by Application in 2024
11.2.7 Cayman Chemical FPR1 Activator Sales by Geographic Area in 2024
11.2.8 Cayman Chemical FPR1 Activator SWOT Analysis
11.2.9 Cayman Chemical Recent Developments
11.3 Tocris Bioscience
11.3.1 Tocris Bioscience Corporation Information
11.3.2 Tocris Bioscience Business Overview
11.3.3 Tocris Bioscience FPR1 Activator Product Models, Descriptions and Specifications
11.3.4 Tocris Bioscience FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Tocris Bioscience FPR1 Activator Sales by Product in 2024
11.3.6 Tocris Bioscience FPR1 Activator Sales by Application in 2024
11.3.7 Tocris Bioscience FPR1 Activator Sales by Geographic Area in 2024
11.3.8 Tocris Bioscience FPR1 Activator SWOT Analysis
11.3.9 Tocris Bioscience Recent Developments
11.4 Abcam
11.4.1 Abcam Corporation Information
11.4.2 Abcam Business Overview
11.4.3 Abcam FPR1 Activator Product Models, Descriptions and Specifications
11.4.4 Abcam FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abcam FPR1 Activator Sales by Product in 2024
11.4.6 Abcam FPR1 Activator Sales by Application in 2024
11.4.7 Abcam FPR1 Activator Sales by Geographic Area in 2024
11.4.8 Abcam FPR1 Activator SWOT Analysis
11.4.9 Abcam Recent Developments
11.5 R&D Systems
11.5.1 R&D Systems Corporation Information
11.5.2 R&D Systems Business Overview
11.5.3 R&D Systems FPR1 Activator Product Models, Descriptions and Specifications
11.5.4 R&D Systems FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 R&D Systems FPR1 Activator Sales by Product in 2024
11.5.6 R&D Systems FPR1 Activator Sales by Application in 2024
11.5.7 R&D Systems FPR1 Activator Sales by Geographic Area in 2024
11.5.8 R&D Systems FPR1 Activator SWOT Analysis
11.5.9 R&D Systems Recent Developments
11.6 MedChemExpress
11.6.1 MedChemExpress Corporation Information
11.6.2 MedChemExpress Business Overview
11.6.3 MedChemExpress FPR1 Activator Product Models, Descriptions and Specifications
11.6.4 MedChemExpress FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 MedChemExpress Recent Developments
11.7 Santa Cruz Biotechnology
11.7.1 Santa Cruz Biotechnology Corporation Information
11.7.2 Santa Cruz Biotechnology Business Overview
11.7.3 Santa Cruz Biotechnology FPR1 Activator Product Models, Descriptions and Specifications
11.7.4 Santa Cruz Biotechnology FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Santa Cruz Biotechnology Recent Developments
11.8 BioVision Inc.
11.8.1 BioVision Inc. Corporation Information
11.8.2 BioVision Inc. Business Overview
11.8.3 BioVision Inc. FPR1 Activator Product Models, Descriptions and Specifications
11.8.4 BioVision Inc. FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 BioVision Inc. Recent Developments
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Corporation Information
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences FPR1 Activator Product Models, Descriptions and Specifications
11.9.4 Enzo Life Sciences FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Enzo Life Sciences Recent Developments
11.10 Selleck Chemicals
11.10.1 Selleck Chemicals Corporation Information
11.10.2 Selleck Chemicals Business Overview
11.10.3 Selleck Chemicals FPR1 Activator Product Models, Descriptions and Specifications
11.10.4 Selleck Chemicals FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Selleck Chemicals Recent Developments
11.11 APPTEC
11.11.1 APPTEC Corporation Information
11.11.2 APPTEC Business Overview
11.11.3 APPTEC FPR1 Activator Product Models, Descriptions and Specifications
11.11.4 APPTEC FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 APPTEC Recent Developments
11.12 Liding Biotechnology
11.12.1 Liding Biotechnology Corporation Information
11.12.2 Liding Biotechnology Business Overview
11.12.3 Liding Biotechnology FPR1 Activator Product Models, Descriptions and Specifications
11.12.4 Liding Biotechnology FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Liding Biotechnology Recent Developments
11.13 Zhiyuan Biotechnology
11.13.1 Zhiyuan Biotechnology Corporation Information
11.13.2 Zhiyuan Biotechnology Business Overview
11.13.3 Zhiyuan Biotechnology FPR1 Activator Product Models, Descriptions and Specifications
11.13.4 Zhiyuan Biotechnology FPR1 Activator Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Zhiyuan Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 FPR1 Activator Industry Chain
12.2 FPR1 Activator Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 FPR1 Activator Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 FPR1 Activator Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 FPR1 Activator Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global FPR1 Activator Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Sigma-aldrich
Cayman Chemical
Tocris Bioscience
Abcam
R&D Systems
MedChemexpress LLC
Santa Cruz Biotechnology
BioVision
Enzo Life Sciences
Selleck Chemicals
AppTec
Zhiyuan Biotechnology
Liding Biotechnology
R&D Systems
List of Tables
 Table 1. Global FPR1 Activator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global FPR1 Activator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global FPR1 Activator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global FPR1 Activator Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global FPR1 Activator Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global FPR1 Activator Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global FPR1 Activator Sales by Region (2020-2025) & (K Dose)
 Table 8. Global FPR1 Activator Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global FPR1 Activator Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global FPR1 Activator Sales Share by Manufacturers (2020-2025)
 Table 12. Global FPR1 Activator Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global FPR1 Activator Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global FPR1 Activator by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FPR1 Activator as of 2024)
 Table 16. Global FPR1 Activator Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global FPR1 Activator Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers FPR1 Activator Manufacturing Base and Headquarters
 Table 19. Global FPR1 Activator Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global FPR1 Activator Sales by Type (2020-2025) & (K Dose)
 Table 23. Global FPR1 Activator Sales by Type (2026-2031) & (K Dose)
 Table 24. Global FPR1 Activator Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global FPR1 Activator Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global FPR1 Activator ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global FPR1 Activator Sales by Application (2020-2025) & (K Dose)
 Table 29. Global FPR1 Activator Sales by Application (2026-2031) & (K Dose)
 Table 30. FPR1 Activator High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global FPR1 Activator Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global FPR1 Activator Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global FPR1 Activator ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America FPR1 Activator Growth Accelerators and Market Barriers
 Table 37. North America FPR1 Activator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America FPR1 Activator Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe FPR1 Activator Growth Accelerators and Market Barriers
 Table 40. Europe FPR1 Activator Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe FPR1 Activator Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific FPR1 Activator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific FPR1 Activator Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific FPR1 Activator Growth Accelerators and Market Barriers
 Table 45. Southeast Asia FPR1 Activator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America FPR1 Activator Investment Opportunities and Key Challenges
 Table 47. Central and South America FPR1 Activator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa FPR1 Activator Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa FPR1 Activator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Sigma-Aldrich Corporation Information
 Table 51. Sigma-Aldrich Description and Major Businesses
 Table 52. Sigma-Aldrich Product Models, Descriptions and Specifications
 Table 53. Sigma-Aldrich Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Sigma-Aldrich Sales Value Proportion by Product in 2024
 Table 55. Sigma-Aldrich Sales Value Proportion by Application in 2024
 Table 56. Sigma-Aldrich Sales Value Proportion by Geographic Area in 2024
 Table 57. Sigma-Aldrich FPR1 Activator SWOT Analysis
 Table 58. Sigma-Aldrich Recent Developments
 Table 59. Cayman Chemical Corporation Information
 Table 60. Cayman Chemical Description and Major Businesses
 Table 61. Cayman Chemical Product Models, Descriptions and Specifications
 Table 62. Cayman Chemical Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. Cayman Chemical Sales Value Proportion by Product in 2024
 Table 64. Cayman Chemical Sales Value Proportion by Application in 2024
 Table 65. Cayman Chemical Sales Value Proportion by Geographic Area in 2024
 Table 66. Cayman Chemical FPR1 Activator SWOT Analysis
 Table 67. Cayman Chemical Recent Developments
 Table 68. Tocris Bioscience Corporation Information
 Table 69. Tocris Bioscience Description and Major Businesses
 Table 70. Tocris Bioscience Product Models, Descriptions and Specifications
 Table 71. Tocris Bioscience Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Tocris Bioscience Sales Value Proportion by Product in 2024
 Table 73. Tocris Bioscience Sales Value Proportion by Application in 2024
 Table 74. Tocris Bioscience Sales Value Proportion by Geographic Area in 2024
 Table 75. Tocris Bioscience FPR1 Activator SWOT Analysis
 Table 76. Tocris Bioscience Recent Developments
 Table 77. Abcam Corporation Information
 Table 78. Abcam Description and Major Businesses
 Table 79. Abcam Product Models, Descriptions and Specifications
 Table 80. Abcam Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. Abcam Sales Value Proportion by Product in 2024
 Table 82. Abcam Sales Value Proportion by Application in 2024
 Table 83. Abcam Sales Value Proportion by Geographic Area in 2024
 Table 84. Abcam FPR1 Activator SWOT Analysis
 Table 85. Abcam Recent Developments
 Table 86. R&D Systems Corporation Information
 Table 87. R&D Systems Description and Major Businesses
 Table 88. R&D Systems Product Models, Descriptions and Specifications
 Table 89. R&D Systems Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. R&D Systems Sales Value Proportion by Product in 2024
 Table 91. R&D Systems Sales Value Proportion by Application in 2024
 Table 92. R&D Systems Sales Value Proportion by Geographic Area in 2024
 Table 93. R&D Systems FPR1 Activator SWOT Analysis
 Table 94. R&D Systems Recent Developments
 Table 95. MedChemExpress Corporation Information
 Table 96. MedChemExpress Description and Major Businesses
 Table 97. MedChemExpress Product Models, Descriptions and Specifications
 Table 98. MedChemExpress Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. MedChemExpress Recent Developments
 Table 100. Santa Cruz Biotechnology Corporation Information
 Table 101. Santa Cruz Biotechnology Description and Major Businesses
 Table 102. Santa Cruz Biotechnology Product Models, Descriptions and Specifications
 Table 103. Santa Cruz Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Santa Cruz Biotechnology Recent Developments
 Table 105. BioVision Inc. Corporation Information
 Table 106. BioVision Inc. Description and Major Businesses
 Table 107. BioVision Inc. Product Models, Descriptions and Specifications
 Table 108. BioVision Inc. Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. BioVision Inc. Recent Developments
 Table 110. Enzo Life Sciences Corporation Information
 Table 111. Enzo Life Sciences Description and Major Businesses
 Table 112. Enzo Life Sciences Product Models, Descriptions and Specifications
 Table 113. Enzo Life Sciences Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 114. Enzo Life Sciences Recent Developments
 Table 115. Selleck Chemicals Corporation Information
 Table 116. Selleck Chemicals Description and Major Businesses
 Table 117. Selleck Chemicals Product Models, Descriptions and Specifications
 Table 118. Selleck Chemicals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 119. Selleck Chemicals Recent Developments
 Table 120. APPTEC Corporation Information
 Table 121. APPTEC Description and Major Businesses
 Table 122. APPTEC Product Models, Descriptions and Specifications
 Table 123. APPTEC Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 124. APPTEC Recent Developments
 Table 125. Liding Biotechnology Corporation Information
 Table 126. Liding Biotechnology Description and Major Businesses
 Table 127. Liding Biotechnology Product Models, Descriptions and Specifications
 Table 128. Liding Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 129. Liding Biotechnology Recent Developments
 Table 130. Zhiyuan Biotechnology Corporation Information
 Table 131. Zhiyuan Biotechnology Description and Major Businesses
 Table 132. Zhiyuan Biotechnology Product Models, Descriptions and Specifications
 Table 133. Zhiyuan Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 134. Zhiyuan Biotechnology Recent Developments
 Table 135. Key Raw Materials Distribution
 Table 136. Raw Materials Key Suppliers
 Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 138. Milestones in Production Technology Evolution
 Table 139. Distributors List
 Table 140. Market Trends and Market Evolution
 Table 141. Market Drivers and Opportunities
 Table 142. Market Challenges, Risks, and Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources


List of Figures
 Figure 1. FPR1 Activator Product Picture
 Figure 2. Global FPR1 Activator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Natural Product Activator Product Picture
 Figure 4. Synthetic Activator Product Picture
 Figure 5. Global FPR1 Activator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Biomedicine
 Figure 7. Drug Discovery
 Figure 8. Clinical Diagnosis
 Figure 9. FPR1 Activator Report Years Considered
 Figure 10. Global FPR1 Activator Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 12. Global FPR1 Activator Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global FPR1 Activator Revenue Market Share by Region (2020-2031)
 Figure 14. Global FPR1 Activator Sales (2020-2031) & (K Dose)
 Figure 15. Global FPR1 Activator Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 16. Global FPR1 Activator Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers FPR1 Activator Sales Volume Market Share in 2024
 Figure 18. Global FPR1 Activator Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Natural Product Activator Revenue Market Share by Manufacturer in 2024
 Figure 21. Synthetic Activator Revenue Market Share by Manufacturer in 2024
 Figure 22. Global FPR1 Activator Sales Market Share by Type (2020-2031)
 Figure 23. Global FPR1 Activator Revenue Market Share by Type (2020-2031)
 Figure 24. Global FPR1 Activator Sales Market Share by Application (2020-2031)
 Figure 25. Global FPR1 Activator Revenue Market Share by Application (2020-2031)
 Figure 26. North America FPR1 Activator Sales YoY (2020-2031) & (K Dose)
 Figure 27. North America FPR1 Activator Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers FPR1 Activator Sales Revenue (US$ Million) in 2024
 Figure 29. North America FPR1 Activator Sales Volume (K Dose) by Type (2020- 2031)
 Figure 30. North America FPR1 Activator Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America FPR1 Activator Sales Volume (K Dose) by Application (2020-2031)
 Figure 32. North America FPR1 Activator Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe FPR1 Activator Sales YoY (2020-2031) & (K Dose)
 Figure 37. Europe FPR1 Activator Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers FPR1 Activator Sales Revenue (US$ Million) in 2024
 Figure 39. Europe FPR1 Activator Sales Volume (K Dose) by Type (2020-2031)
 Figure 40. Europe FPR1 Activator Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe FPR1 Activator Sales Volume (K Dose) by Application (2020-2031)
 Figure 42. Europe FPR1 Activator Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 44. France FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific FPR1 Activator Sales YoY (2020-2031) & (K Dose)
 Figure 49. Asia-Pacific FPR1 Activator Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers FPR1 Activator Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific FPR1 Activator Sales Volume (K Dose) by Type (2020- 2031)
 Figure 52. Asia-Pacific FPR1 Activator Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific FPR1 Activator Sales Volume (K Dose) by Application (2020-2031)
 Figure 54. Asia-Pacific FPR1 Activator Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 59. India FPR1 Activator Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America FPR1 Activator Sales YoY (2020-2031) & (K Dose)
 Figure 61. Central and South America FPR1 Activator Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers FPR1 Activator Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America FPR1 Activator Sales Volume (K Dose) by Type (2021-2031)
 Figure 64. Central and South America FPR1 Activator Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America FPR1 Activator Sales Volume (K Dose) by Application (2020-2031)
 Figure 66. Central and South America FPR1 Activator Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil FPR1 Activator Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina FPR1 Activator Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa FPR1 Activator Sales YoY (2020-2031) & (K Dose)
 Figure 70. Middle East and Africa FPR1 Activator Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers FPR1 Activator Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa FPR1 Activator Sales Volume (K Dose) by Type (2021-2031)
 Figure 73. South America FPR1 Activator Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa FPR1 Activator Sales Volume (K Dose) by Application (2020-2031)
 Figure 75. Middle East and Africa FPR1 Activator Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries FPR1 Activator Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey FPR1 Activator Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt FPR1 Activator Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa FPR1 Activator Revenue (2020-2025) & (US$ Million)
 Figure 80. FPR1 Activator Industry Chain Mapping
 Figure 81. Regional FPR1 Activator Manufacturing Base Distribution (%)
 Figure 82. Global FPR1 Activator Production Market Share by Region (2020-2031)
 Figure 83. FPR1 Activator Production Process
 Figure 84. Regional FPR1 Activator Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global FPR1 Inhibitor Market Research Report 2024
Global FPR1 Antibody Market Research Report 2024
Global Sphingosine 1 Phosphate Receptor 1 Market Insights Forecast to 2030
Global Sphingosine 1 Phosphate Receptor S1PR Modulator Market Research Report 2024
Sphingosine 1 Receptor Modulators Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GIP 1 Receptor Agonist Market Research Report 2024
Global N Formyl Peptide Market Research Report 2024
Global SFRP1 ELISA Kits Market Research Report 2024
Global S1P Receptor Modulator Drugs Market Research Report 2025
Global Adjuvant Peptide Market Research Report 2024
Fibroblast Activation Protein Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global FOLR1 ELISA Kits Market Research Report 2024
Global Plant Activator Market Research Report 2024
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global Activin A Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
GPCR targeting Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IL 6R Agonist Market Research Report 2024
Global Cell Activation Reagent Market Research Report 2024
Global Specific Plasminogen Activator Market Research Report 2024
Global GPCR Assay Kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions